Metformin use before COVID-19 vaccination and the risks of COVID-19 incidence, medical utilization, and all-cause mortality in patients with type 2 diabetes mellitus-Reference-Cited by-同舟云学术

Metformin use before COVID-19 vaccination and the risks of COVID-19 incidence, medical utilization, and all-cause mortality in patients with type 2 diabetes mellitus

Published:2023-06 Issue: Volume:200 Page:110692
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Yen Fu-Shun,Wang Shiow-Ing,Lin Shih-Yi,Wei James Cheng-Chung

Funder

Chung Shan Medical University Hospital

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference29 articles.

1. The changing epidemiology of SARS-CoV-2;Koelle;Science,2022

2. World Health Organization (WHO). WHO Coronavirus (COVID-19) dashboard, https://covid19.who.int/table; 2022 [accessed 16 December 2022].

3. Stopping pandemics before they start: lessons learned from SARS-CoV-2;Edwards;Science,2022

4. COVID-19 vaccination in patients with diabetes mellitus: current concepts, uncertainties and challenges;Pal;Diabetes Metab Syndr,2021

5. Practical recommendations for the management of diabetes in patients with COVID-19;Bornstein;Lancet Diabetes Endocrinol,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coordination chemistry suggests that independently observed benefits of metformin and Zn2+ against COVID-19 are not independent;BioMetals;2024-04-05

2. Old drug, new tricks: the utility of metformin in infection and vaccination responses to influenza and SARS-CoV-2 in older adults;Frontiers in Aging;2023-10-11